Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Overview
Paper Summary
The guideline recommends endoscopic ultrasound (EUS) as the primary tool for characterizing subepithelial lesions (SELs). It suggests tissue diagnosis for SELs with GIST features if they are >20mm or high-risk, recommends endoscopic resection for growing type 1 gastric NENs, and advises against surveillance for most benign SELs if the diagnosis is clear.
Explain Like I'm Five
Scientists found that doctors have new rules to check bumps inside your tummy using a special camera. They learn which bumps need to be taken out and which ones are okay to leave alone.
Possible Conflicts of Interest
Some authors disclosed receiving lecture fees, honoraria, research support, and consulting fees from various medical device and pharmaceutical companies, such as Olympus, Erbe, Boston Scientific, Cook Medical, Medtronics, Abbvie, Novartis, Bayer, Deciphera, and Roche. While these are disclosed, they could represent a potential conflict of interest influencing recommendations related to specific procedures or devices.
Identified Limitations
Rating Explanation
This guideline provides valuable recommendations for managing subepithelial lesions and neuroendocrine neoplasms using endoscopy. Although based mainly on retrospective studies and expert opinion, it offers a structured approach to diagnosis, surveillance, and resection, addressing a clinically important area with limited high-quality evidence. The disclosed conflicts of interest are noted and considered in the rating.
Good to know
This is the Starter analysis. Paperzilla Pro fact-checks every citation, researches author backgrounds and funding sources, and uses advanced AI reasoning for more thorough insights.
Explore Pro →